TLDR
- Jefferies increased XOM’s price target from $178 to $184, suggesting approximately 18.25% potential upside while keeping a “buy” stance.
- Exxon delivered Q4 EPS of $1.71, surpassing the $1.63 estimate, alongside revenue of $80.04 billion.
- Geopolitical tensions with Iran disrupted approximately 6% of Exxon’s worldwide production, applying short-term earnings headwinds.
- Wells Fargo elevated XOM to “overweight” with a $185 price objective; analyst consensus stands at “Moderate Buy” with a mean target of $157.42.
- Expansion in Guyana’s operations and the Permian Basin provides Exxon with production diversity beyond the unstable Middle East region.
Exxon Mobil’s (XOM) positive investment thesis persists even as mixed messages emerge from both Wall Street analysts and Middle Eastern developments. The energy giant is managing geopolitical challenges while analysts keep elevating their price forecasts.
Jefferies increased its price objective from $178 to $184 this past Thursday, retaining a “buy” recommendation. This revision suggests approximately 18.25% potential appreciation from current trading levels. Wells Fargo similarly upgraded XOM to “overweight” with a $185 target, injecting additional bullish sentiment.
Not all analysts share this enthusiasm. Wolfe Research reduced its target from $158 to $153, while BMO Capital Markets maintained a “market perform” stance with a $155 forecast. The broader Wall Street consensus reflects a “Moderate Buy,” derived from 13 Buy ratings, seven Hold ratings, and one Sell rating, averaging $157.42 per share.
XOM closed Thursday at $155.61, experiencing a modest decline during the session. The energy giant commands a market capitalization near $648 billion, trades at a P/E ratio of 23.30, and holds a 50-day moving average of $154.
Regarding quarterly performance, XOM exceeded Q4 projections. The corporation reported earnings per share of $1.71, outperforming the $1.63 consensus forecast. Revenue reached $80.04 billion, beating the anticipated $77.98 billion, despite registering a 1.3% decline compared to the previous year.
Geopolitical tensions involving Iran are generating tangible near-term obstacles for Exxon. The corporation revealed that approximately 6% of its worldwide production capacity experienced interruptions. Company leadership also indicated that Q1 upstream and downstream performance would face negative impacts. Conversely, Exxon noted that elevated crude oil and natural gas prices stemming from the conflict might enhance Q1 upstream earnings by up to $2.9 billion.
A brief cessation of hostilities near the Strait of Hormuz temporarily improved market confidence, pushing crude prices downward and weighing on XOM during early trading. However, shipping routes through the critical waterway remain compromised, and insurance providers continue exercising caution.
Guyana and the Permian Provide a Buffer
Exxon’s expansion narrative beyond Middle Eastern operations represents a crucial element of the bullish investment case. Output from the Stabroek Block offshore Guyana has expanded rapidly and currently stands as among the company’s most significant growth drivers.
The Pioneer Natural Resources acquisition has also gained momentum within the Permian Basin, providing Exxon with an expanded, more cost-efficient production platform in West Texas. The Permian’s rapid-cycle characteristics enable Exxon to adjust more swiftly to market dynamics than competitors dependent on politically sensitive projects.
Valuation Debate
XOM has surged approximately 61% during the past twelve months, prompting certain analysts to question remaining upside potential. Trading at roughly 21x projected 2026 EPS of $7.4, the valuation exceeds historical norms for integrated oil companies.
Exxon’s 12-month peak reached $176.41; its 12-month trough was $97.80. Corporate insiders divested 11,460 shares valued at $1.69 million during the most recent quarter. Institutional ownership accounts for 61.80% of outstanding shares.
Erste Group analysts elevated their FY2026–FY2027 EPS projections for Exxon, pointing to strengthening core profitability expectations. The mean analyst full-year EPS forecast stands at $7.43.





